Recombinant human PRG4 (rhPRG4) suppresses breast cancer cell invasion by inhibiting TGFβ-Hyaluronan-CD44 signalling pathway

Author:

Sarkar Anusi,Chanda Ayan,Regmi Suresh C.,Karve Kunal,Deng Lili,Jay Gregory D.,Jirik Frank R.,Schmidt Tannin A.,Bonni ShirinORCID

Funder

University of Calgary (UC) Eyes High Doctoral Recruitment Scholarship

William H. Davies Medical Research Scholarship

UC Eyes High International Doctoral Scholarship

UC Doctoral Scholarship

Canadian Cancer Society

Faculty of Kinesiology Seed Grant

Natural Sciences and Engineering Research Council of Canada

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference58 articles.

1. Essentials of Cell Biology;C O'Connor,2010

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;F Bray;CA Cancer J Clin.,2018

3. A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments;K Masui;Carcinogenesis,2013

4. Molecular characterization and targeted therapeutic approaches in breast cancer;A Toss;Breast Cancer Res,2015

5. Triple negative breast cancer: the kiss of death;AA Jitariu;Oncotarget,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3